RNA — Avidity Biosciences Share News
0.000.00%
Last trade - 00:00- $11.27bn
- $9.40bn
- $10.90m
Brief: Avidity Biosciences announces inducement grants under Nasdaq listing rule 5635(C)(4)
Brief: Avidity Biosciences Announces Positive Topline Del-Zota Data In DMD44 Trial
Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty
U.S. STOCKS ON THE MOVE-HubSpot, Casey's General Stores, ANI Pharma
U.S. STOCKS ON THE MOVE-Corvus, Dogwood Therapeutics, Uranium Energy
U.S. STOCKS ON THE MOVE-Intel, Groupon, Stitch Fix
BMO starts coverage on Avidity with 'outperform', says first-in-disease therapies in sight
Avidity Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Avidity Biosciences Announces Inducement Grants
U.S. RESEARCH ROUNDUP- Apple, Murphy USA, UnitedHealth
Brief: Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Avidity Biosciences Confirms Accelerated Approval Path for Del-Zota with BLA Planned For Year End 2025
Brief: Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Allstate, Mongodb, Primerica
Brief: Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Avidity Biosciences Inc reports results for the quarter - Earnings Summary
Brief: Avidity Biosciences Pursues Potential Accelerated Approval Path With Initiation Of Biomarker Cohort In FORTITUDE Trial For Delpacibart Braxlosiran (del-brax/AOC 1020) In People Living With Facioscapulohumeral Muscular Dystrophy
U.S. STOCKS ON THE MOVE-InvenTrust Properties, Vistra, MarketAxess
U.S. STOCKS ON THE MOVE-First Foundation, InvenTrust Properties, energy stocks